Prognostic Value of Dobutamine Stress Echocardiography in Patients With Diabetes
Prognostic Value of Dobutamine Stress Echocardiography in Patients With Diabetes Fabiola B. Sozzi , MD, PHD 1 , Abdou Elhendy , MD, PHD 1 , Jos R.T.C. Roelandt , MD, PHD 1 , Ron T. van Domburg , PhD 1 , Arend F.L. Schinkel , MD 1 , Eleni C. Vourvouri , MD 1 , Jeroen J. Bax , MD, PHD 1 , Johan De Sut...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2003-04, Vol.26 (4), p.1074-1078 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Prognostic Value of Dobutamine Stress Echocardiography in Patients With Diabetes
Fabiola B. Sozzi , MD, PHD 1 ,
Abdou Elhendy , MD, PHD 1 ,
Jos R.T.C. Roelandt , MD, PHD 1 ,
Ron T. van Domburg , PhD 1 ,
Arend F.L. Schinkel , MD 1 ,
Eleni C. Vourvouri , MD 1 ,
Jeroen J. Bax , MD, PHD 1 ,
Johan De Sutter , MD, PHD 1 ,
Alberico Borghetti , MD 2 and
Don Poldermans , MD, PHD 1
1 Erasmus Medical Centre, Rotterdam, the Netherlands
2 Department of Internal Medicine, Parma University, Parma, Italy
Abstract
OBJECTIVE —The aim of this study was to assess the incremental value of dobutamine stress echocardiography (DSE) for the risk stratification
of diabetic patients who are unable to perform an adequate exercise stress test. Exercise capacity is frequently impaired
in patients with diabetes. The role of pharmacologic stress echocardiography in the risk stratification of diabetic patients
has not been well defined.
RESEARCH DESIGN AND METHODS —We studied 396 diabetic patients (mean age 61 ± 11 years, 252 men [64%]) with limited exercise capacity who underwent DSE
for evaluation of known or suspected coronary artery disease (CAD). End points were hard cardiac events (cardiac death and
nonfatal myocardial infarction) and all causes of mortality.
RESULTS —During a median follow-up of 3 years, 97 patients (24%) died (55 cardiac deaths), and 27 patients had nonfatal myocardial
infarction. In an incremental multivariate analysis model, clinical predictors of hard cardiac events were history of congestive
heart failure, previous myocardial infarction, hypercholesterolemia, and ejection fraction at rest. The percentage of ischemic
segments was incremental to the clinical model in the prediction of hard cardiac events (χ 2 = 37 vs. 18, P < 0.05). Clinical predictors of all causes of mortality were history of congestive heart failure, age, hypercholesterolemia,
and ejection fraction at rest. Wall motion score index at peak stress was incremental to the clinical model in the prediction
of mortality (χ 2 = 52 vs. 43, P < 0.05).
CONCLUSIONS —DSE provides incremental data for the prediction of mortality and hard cardiac events in patients with diabetes who are unable
to perform an adequate exercise stress test.
CAD, coronary artery disease
DSE, dobutamine stress echocardiography
LV, left ventricular
Footnotes
Address correspondence and reprint requests to Don Poldermans, MD, Thoraxcenter, BA 302, 3015 GD Rotterdam, The Netherlands.
E-mail: poldermans{at}hlkd.azr.nl .
Received for |
---|---|
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/diacare.26.4.1074 |